The immunoglobulin-like transcript-4 (ILT4) is an inhibitory receptor that modulates the activity of innate immune agents. We determined the expression of ILT4 and analysed the relationship with the expression of costimulatory proteins and tumor necrosis factor-α (TNF-α) production in monocytes from patients with psoriatic arthritis (PsA) starting anti-TNF treatment.
Bergamini, A., Chimenti, M.s., Baffari, E., Guarino, M., Gigliucci, G., Perricone, C., et al. (2014). Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis. PLOS ONE, 9(3), e92018-e92018 [10.1371/journal.pone.0092018].
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis
BERGAMINI, ALBERTO;CHIMENTI, MARIA SOLE;PERRICONE, ROBERTO
2014-01-01
Abstract
The immunoglobulin-like transcript-4 (ILT4) is an inhibitory receptor that modulates the activity of innate immune agents. We determined the expression of ILT4 and analysed the relationship with the expression of costimulatory proteins and tumor necrosis factor-α (TNF-α) production in monocytes from patients with psoriatic arthritis (PsA) starting anti-TNF treatment.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Downregulation of Immunoglobulin-Like Transcript-4.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
1.13 MB
Formato
Adobe PDF
|
1.13 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
